83090 CPT® code: payer coverage and prior authorization83090 appears in 26 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Blue Cross NC, Blue Shield of California, BlueCross BlueShield of South Carolina, Centene, Cigna, Premera Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Age-Related Macular Degeneration (0765) | not covered | Jan 14, 2026 | payer document |
| Aetna | Alzheimer's Disease Tests (0349) | not covered | Aug 4, 2026 | payer document |
| Aetna | Autism Spectrum Disorders (0648) | not covered | Oct 2, 2025 | payer document |
| Aetna | Biochemical Markers of Bone Remodeling (0562) | not covered | Aug 21, 2026 | payer document |
| Aetna | Erectile Dysfunction and Peyronie's Disease (0007) | not covered | Jul 29, 2026 | payer document |
| Aetna | Homocysteine Testing (0763) | covered if criteria are met | Nov 12, 2025 | payer document |
| Aetna | Infertility (0327) | not covered | Jul 16, 2026 | payer document |
| Aetna | Nonstandard Laboratory Test Panels (0499) | listed, no stance | Aug 3, 2026 | payer document |
| Aetna | Recurrent Pregnancy Loss (0348) | not covered | Jun 23, 2026 | payer document |
| Aetna | Vitamin B-12 Therapy (0536) | covered if criteria are met | Aug 20, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Homocysteine Testing In The Screening Diagnosis And Management Of Cardiovascular Disease And Venous Thromboembolic Disease | unproven / investigational | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disorders | not covered | Feb 18, 2026 | payer document |
| Blue Cross Blue Shield of Massachusetts | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease (016) | unproven / investigational | payer document | |
| Blue Cross NC | Cardiovascular Disease Risk Assessment AHS – G2050 | listed, no stance | Apr 1, 2026 | payer document |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 83001-83993) | Mar 1, 2024 | payer document |
| Blue Cross NC | Testing of Homocysteine Metabolism Related Conditions AHS - M2141 | listed, no stance | Jan 1, 2026 | payer document |
| Blue Cross NC | Vitamin B12 and Methylmalonic Acid Testing AHS - G2014 | listed, no stance | Jan 1, 2026 | payer document |
| Blue Shield of California | Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease (2.04.65) | listed, no stance | payer document | |
| Blue Shield of California | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disorders (2.04.23) | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Cardiovascular Disease Risk Assessment (CAM 188) | listed, no stance | Apr 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Testing of Homocysteine Metabolism-Related Conditions (CAM 162) Code Number | listed, no stance | Jan 1, 2026 | payer document |
| Centene | Homocysteine T | esting (CP.MP.121) | covered if criteria are met | Mar 1, 2023 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Premera Blue Cross | Cardiovascular Risk Panels (2.04.509) | listed, no stance | Feb 23, 2026 | payer document |
| Premera Blue Cross | Testing of Homocysteine Metabolism-Related Conditions | listed, no stance | Feb 6, 2026 | payer document |
| Premera Blue Cross | Vitamin B12 And Methylmalonic Acid Testing | listed, no stance | Oct 14, 2025 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.